E. Cohen

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Dina V. Hingorani, S. Adams, J. S. Gutkind, 2022, Nature Communications.

Positive Surgical Margins in the 10 Most Common Solid Cancers

Anne Wallace, Karen Messer, Ryan K Orosco, 2018, Scientific Reports.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

R. Ferris, R. Hershberg, G. Dietsch, 2014, Journal of Immunotherapy for Cancer.

Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin

T. Seiwert, M. Lingen, M. Rosner, 2011, Head & neck.